Identification of a Quinolone-Based Scaffold as a Dual SARS-COV-2 PLᵖʳᵒ and Mᵖʳᵒ Inhibitor: An Integrated Molecular Modeling and In-vitro Evaluation Approach
Drug Design, Development and Therapy · 2026-05 · Volume 20 · 1-19
DOI: 10.2147/dddt.s593126 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Design, Development and Therapy, 2026-05. Verfasst von Noor Atatreh und 5 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, Al Ain University, Abu Dhabi, United Arab Emirates. Hauptthemen laut MEDLINE: Antiviral Agents, SARS-CoV-2, Quinolones, Protease Inhibitors. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Pharmacy, Al Ain University, Abu Dhabi, United Arab Emirates.
- AAU Health and Biomedical Research Center, Al Ain University, Abu Dhabi, United Arab Emirates.
- Science Division, New York University, Abu Dhabi, 129188, United Arab Emirates.
ORCID-Profile: Radwa E Mahgoub, Mohammad A Ghattas
Zitieren
APA
Atatreh, N., Bustanji, L., Ferreira, J. C., Rabeh, W. M., Mahgoub, R. E., & Ghattas, M. A. (2026). Identification of a Quinolone-Based Scaffold as a Dual SARS-COV-2 PLᵖʳᵒ and Mᵖʳᵒ Inhibitor: An Integrated Molecular Modeling and In-vitro Evaluation Approach. Drug Design, Development and Therapy, Volume 20, 1-19. https://doi.org/10.2147/dddt.s593126
Vancouver
Atatreh N, Bustanji L, Ferreira JC, Rabeh WM, Mahgoub RE, Ghattas MA. Identification of a Quinolone-Based Scaffold as a Dual SARS-COV-2 PLᵖʳᵒ and Mᵖʳᵒ Inhibitor: An Integrated Molecular Modeling and In-vitro Evaluation Approach. Drug Design, Development and Therapy. 2026;Volume 20:1-19. doi:10.2147/dddt.s593126
BibTeX
@article{Atatreh2026,
author = {Atatreh, Noor and Bustanji, Lana and Ferreira, Juliana C and Rabeh, Wael M and Mahgoub, Radwa E and Ghattas, Mohammad A},
title = {Identification of a Quinolone-Based Scaffold as a Dual SARS-COV-2 PLᵖʳᵒ and Mᵖʳᵒ Inhibitor: An Integrated Molecular Modeling and In-vitro Evaluation Approach},
journal = {Drug Design, Development and Therapy},
year = {2026},
volume = {Volume 20},
pages = {1--19},
doi = {10.2147/dddt.s593126}
}
EUVIMED